Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation
ConclusionIn this propensity-matched and -weighted analysis using a real-world population-based cohort, use of NOACs was associated with lower dementia risk than use of warfarin among non-valvular AF patients initiating OAC treatment.
Source: Europace - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Cardiology | Coumadin | Databases & Libraries | Dementia | Health Insurance | Insurance | Pradaxa | Stroke | Study | Warfarin | Women